Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.
about
Cognitive enhancers for the treatment of ADHDAssociations of sleep disturbance with ADHD: implications for treatmentProfile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorderClinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsEfficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short Form.Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.Development and validation of a simple, sensitive and accurate LC-MS/MS method for the determination of guanfacine, a selective α2A -adrenergicreceptor agonist, in plasma and its application to a pharmacokinetic study.Population pharmacokinetic/pharmacodynamic modeling of guanfacine effects on QTc and heart rate in pediatric patients.The involvement of noradrenaline in rapid eye movement sleep mentation.Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorderGuanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry.Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.The safety of extended-release drug formulations for the treatment of ADHD.Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.Population Pharmacokinetic Modeling of Guanfacine in Pediatric Patients.The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder.Napping reduces emotional attention bias during early childhood.Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release.Sleep-dependent enhancement of emotional memory in early childhood
P2860
Q22251235-CD5F9BB6-C162-4AC3-8116-E3EB56DACB2FQ27027062-918543B6-C20E-4442-BA7A-04BB9DFB2D3AQ27692647-FEEB070A-258F-400A-9011-4F50EB131AD1Q28265059-DF8156FB-CDC1-4D73-B74E-297E0F3B64A1Q34371046-06F07B12-C23A-47E2-8C97-DB6696E14463Q34677924-F11370D0-5421-4B67-91A6-2927B95A652AQ34677931-84B0ACE6-6711-4B8C-A919-19CFDEF3C8C2Q34677936-40822C70-4605-4795-89FF-4F485B746F3FQ34801634-557F2D5B-EC05-4129-9BF7-24E6CBE32EB8Q35318113-3CC755B2-8A63-4C0E-A0A4-C388BE284F6CQ35607222-5C5BAA38-2B86-42FB-8A39-E2A4D54939B6Q36026825-1DA8F67E-CA8E-4073-8C01-637700BA2515Q38011640-180178FC-1622-4BDF-8593-0C6E41935D85Q38187122-7B581648-9AE8-4AA8-962E-228803E1124EQ38225962-3DF9A32C-0020-4F33-8B7B-1EA769F2C4C5Q38387691-ADCBB97C-088C-4980-BAD6-63C2393331B2Q38389306-65420360-C8E4-4657-BFFB-F8D7C70AD040Q38732635-BE187986-3CA0-4FFB-BB7F-35CE11CDA7BAQ38930427-03659222-D428-4F85-BFA3-918241095B28Q39293219-716AE1BD-7964-4094-84D1-64AF0FFC14F4Q41338984-A842CC44-7282-4595-8B79-095DE3AEFFE5Q42070708-5C697D73-08D3-4FF1-B7A2-BE75A849D909Q46584563-761AD644-E640-49C4-A6C0-AD3B94FFBB98Q47847802-E4D530E8-6C5D-472E-B4DE-C5E7BF3F5611Q48017969-A3E7BBC1-0B15-4C91-8658-666695456FAAQ58721644-2F5808A5-817E-4798-8704-40AB5CB68674
P2860
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@en
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@nl
type
label
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@en
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@nl
prefLabel
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@en
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@nl
P2093
P356
P1476
Psychomotor functioning and al ...... eficit/hyperactivity disorder.
@en
P2093
Andrew Lyne
Bradley D Vince
Frank A López
John M Turnbow
Kimberly Farrand
Scott H Kollins
Sharon B Wigal
Thomas Roth
P304
P356
10.1089/CAP.2010.0064
P577
2011-04-10T00:00:00Z